Orchestra BioMed Holdings, Inc. (OBIO) Total liabilities 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) total liabilities at each fiscal year-end, per SEC filings.
$51.5MFY2025 · since FY2022: $43.0M → $51.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $51.5M | +19.1% |
| FY2024 | $43.2M | +59.1% |
| FY2023 | $27.2M | -36.9% |
| FY2022 | $43.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More OBIO financial trends
OBIO RevenueOBIO Net incomeOBIO Net marginOBIO Gross profitOBIO Gross marginOBIO Operating incomeOBIO Operating marginOBIO Operating cash flowOBIO Free cash flowOBIO Capital expendituresOBIO Return on equityOBIO Stock buybacksOBIO Dividends paidOBIO Total assetsOBIO Shareholders’ equityOBIO overview →